RecruitingNot applicableNCT07550348

Bupivacaine-Lidocaine vs Bupivacaine for Ultrasound-Guided Popliteal Sciatic Nerve Block

Studying Paraneoplastic neurologic syndrome

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Ataturk University
Principal Investigator
AHMET MURAT YAYIK, MD, PhD
Ataturk University Faculty of Medicine, Department of Anesthesiology and Reanimation
Intervention
Bupivacaine-Lidocaine Combination(drug)
Enrollment
60 target
Eligibility
18-65 years · All sexes
Timeline
2025 – 2027

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07550348 on ClinicalTrials.gov

Other trials for Paraneoplastic neurologic syndrome

Additional recruiting or active studies for the same condition.

See all trials for Paraneoplastic neurologic syndrome →

← Back to all trials